San Francisco County OBOT Pilot: Pharmacy Aspects Sharon Kotabe, PharmD Associate Administrator for Pharmaceutical Services Associate Clinical Professor.

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

Care Coordinator Roles and Responsibilities
Bakheet Aldosari, Ph.D. Health 305 Health Information Management Bakheet Aldosari, Ph.D.
“Medication Units” (Opioid Treatment Programs) Drug Enforcement Administration James “Jim” Arnold Chief, Policy Unit Office of Diversion Control D E A.
Development and Implementation of a Theme Based Introductory Pharmacy Practice Experience (IPPE) Program S. Scott Wisneski, Pharm.D., MBA, Louis D. Barone,
Drug Utilization Review (DUR)
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
1 “Medicines use review conducted in community pharmacy" Professor Ian Chi Kei Wong Department of Health Public Health Career Scientist The School of Pharmacy.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
a judgment of what constitutes good or bad Audit a systematic and critical examination to examine or verify.
A Patient-Centered Approach with P.R.I.D.E.
Effective Advocacy: Knowledge, Tools & Attitude Presented by Carol Neidenberg January 25, 2012.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
An NTP Affiliated Office-Based Opiate Treatment (OBOT) Program in a Public Health Setting Alice Gleghorn, PhD SFDPH OBOT Director.
Pharmacists Wanted !!! By Alice Chen, Pharm.D. Pharmacy Manager Kaiser Permanente August 6, 2005.
Solution Overview for NIPDEC- CDAP July 15, 2005.
Benton Community Health Center Located at: 530 NW 27 th Street Corvallis, Oregon (inside the Public Services building) Medical Staff consists of: 3 Physicians.
Pharmacy Services.
Aurora Employee Assistance Program
 Definitions  Goals of automation in pharmacy  Advantages/disadvantages of automation  Application of automation to the medication use process  Clinical.
Primary Care Workforce Summit November 29, 2012 Country Springs Hotel, Waukesha Primary Care Workforce Summit Pharmacy Perspective Kate Hartkopf, PharmD.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
Module V: Coordinated Care BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Local Public Health System Assessment using the NPHPSP Local Instrument Essential Service 6 Enforce Laws and Regulations that Protect Health and Ensure.
State Alliance for e-Health Conference Meeting January 26, 2007.
Clinical Pharmacy Part 2
Florida Agency for Health Care Administration Florida Center for Health Information and Policy Analysis Florida Public Health Association - Medical Director’s.
The Role of Case Management in Treatment Courts Presented by Marilyn GibsonOctober 8, 2014.
For Pain or Not for Pain: Methadone Madness
Pharmacy Administrator: Manager / Adminstrator for Pharmacies Research Leader for: oUoUniversities oHoHealth Insurance oPoPharmaceutical Companies.
Together.Today.Tomorrow. The BLUES Project Karen C. Fox, PhD Chief Executive Officer.
Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Documentation of Care Provided Patient’s care - who should do it? WHY DOCUMENT? When should it occur? Where should it be documented? How should it be documented?
Baltimore Buprenorphine Initiative Advancing Recovery Project Baltimore City, Maryland January 14, 2010.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
Expanding Authority for MAT, New Initiatives and Next Steps Brad DeCamp SOTA Ohio Mental Health & Addiction Services.
Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
Marketing Career Project Renee Bass Pharmaceutical/Medical Marketing.
Who are Health-System Pharmacists? Pharmacists are healthcare professionals with extensive education and training in the pharmaceutical sciences. Education.
Bringing Hepatitis C Treatment into the Medical Home A Pilot Program for Drug Users Dr. Joanna Eveland MS, MD, Clinical Chief for Special Populations Mission.
Objectives Identify different types of health care facilities. Describe a typical hospital organizational structure. Identify hospital departments and.
Introduction to Careers in Acute and Ambulatory Settings.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Developing role of community pharmacy in responding to the needs of people with drug problems Karen Melville Principal Pharmacist TSMS NHS Tayside.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
Documentation in Practice Dept. of Clinical Pharmacy.
Medication Assisted Treatment
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Alice Gleghorn, PhD SFDPH OBOT Director
San Francisco County OBOT Pilot: Pharmacy Aspects
Introduction to Clinical Pharmacy
Opioids – A Pharmaceutical Perspective on Prescription Drugs
CHAPTER 4 Information Management in Pharmacy.
Pharmacist- Career Opportunities
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Health Care Providers and Professionals
Primary Care Integration
Pharmacy practice and the healthcare system Ola Ali Nassr
Compounded Drugs and Lack of Premarket FDA-Approval
Hospital pharmacy.
A Training For Multidisciplinary Addiction Professionals
SAMPLE ONLY Dominion Health Center: Your Community Partner for Excellent Care (or another defining message) Dominion Health Center is a community health.
SAMPLE ONLY Dominion Health Center: Your Community Healthcare Home (or another defining message) Dominion Health Center is a community health center.
Presentation transcript:

San Francisco County OBOT Pilot: Pharmacy Aspects Sharon Kotabe, PharmD Associate Administrator for Pharmaceutical Services Associate Clinical Professor of Pharmacy, UCSF

In the beginning…… Pharmacy Subcommittee formed, November 1999 Members represented County Health Department Local School of Pharmacy State Board of Pharmacy State Poison Control System Local chain, independent & hospital pharmacies Narcotic Treatment Programs (NTPs) and free clinics

Pharmacy Subcommittee Charge “ To develop and recommend a ‘best practices’ model to create medically appropriate and geographically- convenient dispensing of methadone in a PHARMACY-BASED SETTING in San Francisco”

Pharmacy Subcommittee Activities Identified barriers to pharmacist participation in project Pharmacists not included in “traditional” maintenance program models and in California, restricted by law from dispensing maintenance opiates to known addicts Negative perceptions & beliefs re: addiction Reimbursement for time necessary to provide appropriate services

Pharmacy Subcommittee Activities Identified benefits of pharmacist participation in program Expertise counseling patients on medication and drug therapy Availability of patient’s entire drug profile for drug-drug interaction and contraindication monitoring Increased access to treatment through local “neighborhood” pharmacies

Pharmacy Subcommittee Activities Reviewed State and Federal regulations for “traditional” narcotic treatment programs Reviewed materials training materials used to educate pharmacy students about addiction and addiction pharmacology from various schools of pharmacy

Pharmacy Subcommittee Activities Met with pharmacists engaged in office- based treatment models in other States Matched zip-codes of clients already in treatment with pharmacy locations to target potential dispensing pharmacies Conducted focus groups with pharmacists from 10 zip-codes with highest number of current clients

Focus Group Comments Support for expanding access to treatment Participation perceived as a natural expansion of professional role and responsibilities and welcomed challenge of learning new skills Suggestions that program start slowly with fewer initial clients, and for scheduled “appointment times”

Pharmacy Subcommittee Recommendations ( February 2001) Training Integrate with training for physicians, counselors and others to foster collaborative, team-approach to care Focus on: (1) “mechanics” of maintenance treatment and, (2) “raising consciousness” on nature of addiction

Recommendations (continued)… Create central database for ready access to relevant client information and recording dose administration Allow pharmacies to establish dosing “appointments” as dictated by workload Require establishment of dosing areas separate and private from main pharmacy counseling windows

Recommendations (continued)… Provide adequate security Provide access to “on-call” system to advise pharmacists dealing with complex client issues Pharmacists provide medication counseling, counselors and physicians provide drug abuse counseling Provide adequate remuneration

….. and at last! First patient enrolled, July 2003 Community pharmacy participation Corporate vs. individual pharmacist views Corporate view prevails County operated pharmacies Hospital-based outpatient pharmacy (methadone dispensing) Mental health clinic pharmacy (buprenorphine dispensing)

Basic Program Components All pharmacists involved in the program undergo extensive training provided by the California Society of Addiction Medicine Central database with pertinent client demographic and clinical information Pharmacists record observed and take home dosing in database Communication and clinical data sharing through “SOAP” notes format

Basic Program Components Program licensure allows exemption from Board of Pharmacy prescription requirements “On-call” OBOT program staff to assist with problems Physical modifications were made to enhance security and dosing area privacy Program uses methadone tablets (vs. liquid or diskette), or Suboxone R

Observations, 1 year later Establishing dosing “appointments” works! Estimate of pharmacist time needed for each observed dosing/take home dispensing (5 minutes) too low Regulatory agencies - e.g. DEA, state NTP licensing agency - complimentary of pharmacist record keeping, security, and professional services provided to clients

more observations…... Rapport between pharmacist and client quickly and easily established Pharmacists enjoy client interaction and expanded responsibilities Pharmacists initially reluctant to “volunteer”, later filed labor grievance to be allowed to participate Clients prefer dosing and receiving take home doses in a pharmacy setting

Lessons Learned Listen to the “experts” - especially those who actually do the work Local buy-in may not be enough, engage corporate decision makers if possible Initial concerns about major legal and regulatory obstacles did not materialize Flexibility, open-mindedness, and patience are required traits for anyone involved in a pilot program

Questions? Sharon Kotabe, PharmD (415)